These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12621333)

  • 1. Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9.
    Mhatre AN; Kim Y; Brodie HA; Lalwani AK
    Otol Neurotol; 2003 Mar; 24(2):205-9. PubMed ID: 12621333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
    Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
    Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
    Arrondel C; Vodovar N; Knebelmann B; Grünfeld JP; Gubler MC; Antignac C; Heidet L
    J Am Soc Nephrol; 2002 Jan; 13(1):65-74. PubMed ID: 11752022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
    Wasano K; Matsunaga T; Ogawa K; Kunishima S
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular genetic analysis of a family with macrothrombocytopenia and early onset sensorineural hearing loss.
    Mhatre AN; Janssens S; Nardi MA; Li Y; Lalwani AK
    Eur J Med Genet; 2009; 52(4):185-90. PubMed ID: 19285578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in MYH9-related thrombocytopenia.
    Dong F; Li S; Pujol-Moix N; Luban NL; Shin SW; Seo JH; Ruiz-Saez A; Demeter J; Langdon S; Kelley MJ
    Br J Haematol; 2005 Aug; 130(4):620-7. PubMed ID: 16098078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.
    Li K; Jin R; Xu W; Shen Y; Lu K; Wu X
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e7-e10. PubMed ID: 32520844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation of a novel MYH9 mutation (p.G736L) in a patient with macrothrombocytopenia and end-stage renal disease.
    Souto Filho JTD; Lemos MM; Piraciaba JCB; Silveira ALO; Lacerda AP; Pires AZ; de Sales LR; Dias YP
    Ann Hematol; 2019 Mar; 98(3):781-782. PubMed ID: 30617524
    [No Abstract]   [Full Text] [Related]  

  • 10. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
    Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
    Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
    Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
    Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation].
    Böttcher A; Knecht R; Busch CJ; Lörincz BB; Dalchow CV
    HNO; 2013 Feb; 61(2):159-60, 162-5. PubMed ID: 23223919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism in MYH9 disorders: the need to carefully evaluate apparently healthy parents.
    Kunishima S; Kitamura K; Matsumoto T; Sekine T; Saito H
    Br J Haematol; 2014 Jun; 165(6):885-7. PubMed ID: 24611568
    [No Abstract]   [Full Text] [Related]  

  • 14. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic Epstein syndrome with macrothrombocytopenia, sensorineural hearing loss and renal failure.
    Makino S; Kunishima S; Ikumi A; Awaguni H; Shinozuka J; Tanaka S; Maruyama R; Imashuku S
    Pediatr Int; 2015 Oct; 57(5):977-81. PubMed ID: 26387855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
    Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
    Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Japanese pedigree with a p.A95V mutation in the MYH9 gene demonstrates inherited macrothrombocytopenia without Alport manifestations.
    Yokoi S; Kunishima S; Takahashi Y; Morishita M; Kojima S
    Ann Hematol; 2016 Apr; 95(5):831-3. PubMed ID: 26861218
    [No Abstract]   [Full Text] [Related]  

  • 18. MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
    Natesirinilkul R; Sosothikul D; Komwilaisak P; Pongtanakul B; Narkbunnum N; Yudhasompop N; Mekjarusgool P; Niparuck P; Boonyawat K; Kunishima S; Sirachainan N;
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29055. PubMed ID: 33855781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.
    De Rocco D; Zieger B; Platokouki H; Heller PG; Pastore A; Bottega R; Noris P; Barozzi S; Glembotsky AC; Pergantou H; Balduini CL; Savoia A; Pecci A
    Eur J Med Genet; 2013 Jan; 56(1):7-12. PubMed ID: 23123319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
    Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
    Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.